# Ensuring Patients' Informed Access to Noninvasive Prenatal Testing

> **NCT03420274** · NA · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 691 (actual)

## Conditions studied

- Genetic Disease
- Genetic Syndrome
- Prenatal Disorder
- Prenatal Maternal Abnormality
- Pregnancy Complications

## Interventions

- **BEHAVIORAL:** NEST
- **BEHAVIORAL:** Usual care

## Key facts

- **NCT ID:** NCT03420274
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-19
- **Primary completion:** 2022-04-30
- **Final completion:** 2023-06-15
- **Target enrollment:** 691 (ACTUAL)
- **Last updated:** 2026-03-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03420274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03420274, "Ensuring Patients' Informed Access to Noninvasive Prenatal Testing". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03420274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*